Bumetanide for neonatal seizures-back from the cotside
Nat Rev Neurol
.
2015 Dec;11(12):724.
doi: 10.1038/nrneurol.2015.116.
Epub 2015 Nov 3.
Authors
Ronit M Pressler
1
,
Geraldine B Boylan
2
,
Neil Marlow
1
,
Linda S de Vries
3
,
Mats Blennow
4
,
Catherine Chiron
5
6
,
J Helen Cross
1
,
Boubou Hallberg
4
,
Lena Hellström-Westas
7
,
Vincent Jullien
5
6
,
Barry Mangum
8
,
Brendan Murphy
2
,
Deirdre Murray
2
,
Gerard Pons
5
6
,
Janet Rennie
1
,
Mona C Toet
9
,
Sarah Zohar
10
;
NEMO consortium (NEonatal seizure treatment with Medication Off-patent)
Affiliations
1
Section of Clinical Neurosciences &Neonatal Unit, University College London, 30 Guilford Street, London WC1N 1EH, UK.
2
Neonatal Brain Research Group, INFANT Research Centre, University College Cork, Ireland.
3
Neonatology, University Medical Center Utrecht, Netherlands.
4
Neonatology, Karolinska University Hospital, Sweden.
5
INSERM U1129, France.
6
University Paris Descartes, France.
7
Department of Women's and Children's Health, Uppsala University, Sweden.
8
Paidion Research, Durham, USA.
9
Universitair Medisch Centrum Utrecht (UMCU), Netherlands.
10
Department for Statistics, INSERM, France.
PMID:
26526530
DOI:
10.1038/nrneurol.2015.116
No abstract available
Publication types
Comment
MeSH terms
Bumetanide*
Female
Humans
Hypoxia-Ischemia, Brain / drug therapy*
Male
Phenobarbital / therapeutic use*
Seizures / drug therapy*
Substances
Bumetanide
Phenobarbital